Literature DB >> 8448823

In vivo and in vitro approaches to study metastasis in human prostatic cancer.

C Lee1, D H Shevrin, J M Kozlowski.   

Abstract

Prostate cancer is the most common malignancy in American males and is second only to lung cancer as a cause of death in the United States. Clinically, radical prostatectomy offers a patient with locally contained disease an excellent chance for cure. For patients with metastatic disease, the current therapies are merely palliative. Understanding the biology of prostate cancer metastasis should facilitate the development of novel and effective therapeutic modalities. Crucial to this objective is the availability of human tumor systems in which the biology of metastasis can be studied. The present chapter will briefly assess various in vivo and in vitro approaches to study metastasis in human prostate cancer. Utilization of athymic nude mice has played an important role in maintaining human prostatic cancer cells as xenografts and has provided an opportunity to establish site-specific subpopulations of the parental cell lines for further characterization and investigation. At present, a few established cell lines have been useful for this purpose. Fresh tumor specimens, unfortunately, have shown limited ability to grow in nude mice. The recent development of novel approaches to permit the maintenance of freshly harvested prostate cancers has been encouraging. The use of reconstituted basement membrane (Matrigel) for co-injection with cancer cells into the subcutaneous tissues has supported growth of biologically indolent tumors. Another approach is to administer tumor cells orthotopically into the prostate of recipient nude mice. Bone marrow metastases in nude mice have been rare in the past. Recently, three approaches have been shown to be successful in accomplishing bony metastasis with PC-3 cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8448823     DOI: 10.1007/bf00689787

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  34 in total

1.  Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha.

Authors:  D R Hofer; E R Sherwood; W D Bromberg; J Mendelsohn; C Lee; J M Kozlowski
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

2.  A rapid in vitro assay for quantitating the invasive potential of tumor cells.

Authors:  A Albini; Y Iwamoto; H K Kleinman; G R Martin; S A Aaronson; J M Kozlowski; R N McEwan
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

3.  Selection of successive tumour lines for metastasis.

Authors:  I J Fidler
Journal:  Nat New Biol       Date:  1973-04-04

4.  Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases.

Authors:  M E Stearns; M Wang
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

5.  Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice.

Authors:  N Hanna; I J Fidler
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

6.  A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice.

Authors:  J M Kozlowski; I R Hart; I J Fidler; N Hanna
Journal:  J Natl Cancer Inst       Date:  1984-04       Impact factor: 13.506

7.  Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice.

Authors:  J L Ware; D F Paulson; G H Mickey; K S Webb
Journal:  J Urol       Date:  1982-11       Impact factor: 7.450

8.  Transplantation of human tumors in nude mice.

Authors:  Y Shimosato; T Kameya; K Nagai; S Hirohashi; T Koide; H Hayashi; T Nomura
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

9.  Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved.

Authors:  H Saitoh; M Hida; T Shimbo; K Nakamura; J Yamagata; T Satoh
Journal:  Cancer       Date:  1984-12-15       Impact factor: 6.860

Review 10.  Advanced prostatic carcinoma. Early versus late endocrine therapy.

Authors:  J M Kozlowski; W J Ellis; J T Grayhack
Journal:  Urol Clin North Am       Date:  1991-02       Impact factor: 2.241

View more
  7 in total

1.  Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber.

Authors:  U Pilatus; E Ackerstaff; D Artemov; N Mori; R J Gillies; Z M Bhujwalla
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

2.  Non-invasive microCT imaging characterization and in vivo targeting of BB2 receptor expression of a PC-3 bone metastasis model.

Authors:  Christopher T Winkelmann; Said Daibes Figueroa; Gary L Sieckman; Tammy L Rold; Timothy J Hoffman
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

3.  Immortal Life of the Common Rule: Ethics, Consent, and the Future of Cancer Research.

Authors:  Joshua D Smith; Andrew C Birkeland; Edward B Goldman; J Chad Brenner; Thomas E Carey; Kayte Spector-Bagdady; Andrew G Shuman
Journal:  J Clin Oncol       Date:  2017-04-20       Impact factor: 44.544

4.  A human xenograft model for testing early events of epithelial neoplastic invasion.

Authors:  J McCandless; A Cress; I Rabinovitz; C Payne; G Bowden; J Knox; R Nagle
Journal:  Int J Oncol       Date:  1997-02       Impact factor: 5.650

5.  Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro.

Authors:  M E Laniado; E N Lalani; S P Fraser; J A Grimes; G Bhangal; M B Djamgoz; P D Abel
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

6.  Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer.

Authors:  Sarvesh Jajoo; Debashree Mukherjea; Tejbeer Kaur; Kelly E Sheehan; Sandeep Sheth; Vikrant Borse; Leonard P Rybak; Vickram Ramkumar
Journal:  Antioxid Redox Signal       Date:  2013-07-05       Impact factor: 8.401

7.  TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence.

Authors:  Qiang Zhang; Lin Chen; Brian T Helfand; Thomas L Jang; Vidit Sharma; James Kozlowski; Timothy Michael Kuzel; Lihua J Zhu; Ximing J Yang; Borko Javonovic; Yinglu Guo; Scott Lonning; Jay Harper; Beverly A Teicher; Charles Brendler; Nengwang Yu; William J Catalona; Chung Lee
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.